BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/15/2016 3:02:00 PM | Browse: 1244 | Download: 1651
 |
Received |
|
2015-04-22 08:50 |
 |
Peer-Review Started |
|
2015-04-23 10:01 |
 |
To Make the First Decision |
|
2015-07-20 14:38 |
 |
Return for Revision |
|
2015-08-02 00:42 |
 |
Revised |
|
2015-08-31 15:17 |
 |
Second Decision |
|
2015-11-03 08:55 |
 |
Accepted by Journal Editor-in-Chief |
|
2015-11-03 14:20 |
 |
Accepted by Executive Editor-in-Chief |
|
2015-11-19 16:26 |
 |
Articles in Press |
|
2015-11-19 16:26 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2015-12-17 21:25 |
 |
Publish the Manuscript Online |
|
2016-01-15 14:54 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
|
Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
|
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Topic Highlights |
Article Title |
Protein tyrosine phosphatase non-receptor type 2 and inflammatory bowel disease
|
Manuscript Source |
Invited Manuscript |
All Author List |
Marianne R Spalinger, Declan F McCole, Gerhard Rogler and Michael Scharl |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Swiss National Science Foundation (SNF) to MS |
314730-146204 (to Rogler G) |
Swiss National Science Foundation (SNF) to MS |
CRSII3_154488/1 (to Rogler G) |
Swiss National Science Foundation (SNF) to MS |
310030-120312 |
Swiss IBD Cohort |
3347CO-108792 |
|
Corresponding Author |
Michael Scharl, MD, Division of Gastroenterology and Hepatology, University Hospital Zurich, Raemistrasse 100, 8091 Zurich, Switzerland. michael.scharl@usz.ch |
Key Words |
Protein tyrosine phosphatase non-receptor type 2; Inflammatory bowel disease; Chronic intestinal inflammation; Barrier function; Phosphorylation |
Core Tip |
Genetic variants and subsequently aberrant function of protein tyrosine phosphatase non-receptor type 2 (PTPN2) have been associated with inflammatory bowel disease (IBD). Protein levels of PTPN2 are increased in the mucosa of IBD patients and PTPN2-deficient mice suffer from severe intestinal as well as systemic inflammation and feature alterations in innate and adaptive immune responses. In the innate immune system, dysfunction of PTPN2 results in increased secretion of pro-inflammatory cytokines, impairs autophagosome formation, and mediates disruption of epithelial barrier function. In the adaptive immune system, PTPN2 is involved in controlling T-cell proliferation, differentiation and promoting T-cell tolerance. Consequently, variants in PTPN2 importantly affect intestinal homeostasis and contribute to IBD pathogenesis.
|
Publish Date |
2016-01-15 14:54 |
Citation |
Spalinger MR, McCole DF, Rogler G, Scharl M. Protein tyrosine phosphatase non-receptor type 2 and inflammatory bowel disease. World J Gastroenterol 2016; 22(3): 1034-1044 |
URL |
http://www.wjgnet.com/1007-9327/full/v22/i3/1034.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v22.i3.1034 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345